Jessica Treptow Babic, PharmD, RPh
Infectious Diseases Pharmacy Fellow – Year 2
Hometown: Austin, TX
PGY1 Residency: Harris Health System; Houston, TX
Current Research: Investigation of polymyxin B pharmacokinetics and nephrotoxicity.
About Me: Jessica's primary area of interest is infectious diseases. After fellowship, she hopes to obtain a clinical specialist or faculty position in ID. In her free time, Jessica enjoys cooking, reading, shopping, and playing trivia.
Why Baylor St. Luke’s Medical Center: Jessica was brought to Baylor St. Luke's due to the unique collaboration between the hospital and the University of Houston, offering one of the few fellowships with a clinical component integrated. During the first year, she will be able to learn from a large group of clinical specialists in a variety of fields and the affiliation with the University of Houston provides for daily interactions with students, as well as a thriving research program in infectious diseases.
Gary Fong, PharmD, RPh
Infectious Diseases Pharmacy Fellow – Year 1
Hometown: Oak Park, CA
PGY1 Residency: University of California, San Francisco Medical Center
Current Research: Evaluating current dosing recommendations for micafungin in C. glabrata infections; specifically evaluating the pharmacokinetic-pharmacodynamic targets that are achievable in both normal and obese patients.
About Me: Gary’s primary interest is in infectious disease, specifically antifungals, gram-positive infections and pharmacokinetics. He is also interested in academia and plans to pursue a career that focuses on both clinical pharmacy as well as teaching. Gary is a big college sports fan and has also picked up a strong interest in the craft during his time in San Francisco, CA.
Why Baylor St. Luke’s Medical Center: Gary was interested in Baylor St. Luke's because it is one of the few places that offer an infectious diseases fellowship. Additionally, he felt that the program has a very strong clinical component alongside the usual research emphasis. He was also impressed by the established role of the infectious diseases pharmacist and the network of infectious diseases pharmacists in the Texas Medical Center.